Esperion Therap (ESPR) Reports In-Line Q2 EPS, Expects ETC-1002-008 Data in Early Oct.

Go back to Esperion Therap (ESPR) Reports In-Line Q2 EPS, Expects ETC-1002-008 Data in Early Oct.
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.15 --0 (-0%)
Previous Close $3.15    52 Week High $30.41 
Open $3.15    52 Week Low $9.40 
Day High $3.15    P/E N/A 
Day Low $3.15    EPS $-21.87 
Volume 19,647